[Antitumor effect of KRN 8602 for malignant brain tumors using collagen gel matrix assay].

MLA

Yuki, K., et al. “[Antitumor Effect of KRN 8602 for Malignant Brain Tumors Using Collagen Gel Matrix Assay].” Gan to Kagaku Ryoho. Cancer & Chemotherapy, vol. 22, no. 10, Sept. 1995, pp. 1403–06. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=7668878&authtype=sso&custid=ns315887.

APA

Yuki, K., Tohru, U., Yasunori, K., Katsuzo, K., & Kaoru, K. (1995). [Antitumor effect of KRN 8602 for malignant brain tumors using collagen gel matrix assay]. Gan to Kagaku Ryoho. Cancer & Chemotherapy, 22(10), 1403–1406.

Chicago

Yuki, K, U Tohru, K Yasunori, K Katsuzo, and K Kaoru. 1995. “[Antitumor Effect of KRN 8602 for Malignant Brain Tumors Using Collagen Gel Matrix Assay].” Gan to Kagaku Ryoho. Cancer & Chemotherapy 22 (10): 1403–6. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=7668878&authtype=sso&custid=ns315887.